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In the March issue of Medical Physics, Chen et al.1 stud-
ied the dosimetric impact of the interplay between the mo-
tion of the multileaf collimator and that of a phantom under-
going simulated lung motion. Beam gating was used to limit
the range of motion during radiation delivery with the goal
of finding the allowable residual motion which produced
“acceptable” dosimetric results. Film measurements were
made in stationary and moving phantoms using simple step-
and-shoot IMRT test patterns and clinical dynamic sliding-
window IMRT fields. Analysis was performed within com-
mercial film analysis software using the gamma index2 to
compare the differences between the dose distributions pro-
duced with or without motion. There are two issues of con-
cern with this work, 1 that the gamma index is an inappro-
priate metric for determining “acceptability” in this situation,
and 2 that the somewhat arbitrary selection of gamma
analysis parameters then determines the clinical recommen-
dation in the conclusion.
In Sec. III C, the authors stated that they adopted gamma
parameters of 5% dose difference and 5 mm distance to
agreement in order to determine which pixels “pass” and
which “fail.” This was done without justification for choos-
ing these values or any statement of what values would nor-
mally be used clinically. One can only speculate that these
values were chosen by analyzing data from a nominally uni-
form field in Figs. 3c and 3d solid line and selecting
parameters which made the results from this field acceptable
when compared to a 1010 cm2 uniform field. The con-
clusions then recommend that a residual motion window of 5
mm be used when selecting a gating window for clinical
implementation of respiratory-gated IMRT.
As expected, any dosimetric discrepancies arising from
offsets or motions less than the distance-to-agreement pa-
rameter used in the gamma analysis yield a passing result.
The conclusion that a 5 mm gating window is acceptable is
really an example of using inappropriate analysis techniques
and the misuse of the gamma index as an analysis tool. The
gamma index was originally intended to compare calculated
and measured distributions generated under the same condi-
tions. The technique and parameters used for analysis of the
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Measurement of the experimental uncertainties involved in
marking and registering films, and the dosimetric variability
expected when making film measurements should be part of
the analysis. These arguments may also be extended to two-
dimensional diode or ion chamber arrays commonly used for
IMRT QA measurements. Any remaining discrepancies
should then be investigated and understood as characteristics
of the planning and delivery systems and the measurement
tools. Examples of such characteristics are light field vs ra-
diation field offsets due to rounded MLC leaf tips, under-
dosed regions due to MLC tongue and groove effect, and
compromises in beam modeling within the planning system
especially in the penumbra region. All too often, it seems
that the error analysis parameters are altered to cover up
discrepancies that are not completely understood, or that
practitioners have no ability to improve.
Though gamma analysis is often used for IMRT QA pass/
fail decisions, it is not used as a dosimetric analysis tool for
this kind of experiment, especially where the spatial integrity
of the experiment is a critical aspect of the experimental
design. While several examples of absolute dose deviations
are shown for a range of residual motions, there is no abso-
lute characterization of these variations. This analysis does
not prove that dosimetric deviations of this order are accept-
able when delivering respiratory-gated IMRT. The actual
magnitude and distribution of dosimetric variations should
be studied within the context of the treatment plan. Whether
the results are acceptable should be determined by the dosi-
metric criteria specified to achieve the desired clinical out-
come.
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